Disclosure of Financial Relationships

As the accredited provider, Des Moines University Medicine and Health Sciences (DMU) is committed to ensuring that accredited continuing education (1) presents learners with only accurate, balanced, scientifically justified recommendations and (2) protects learners from promotion, marketing, and commercial bias. DMU is responsible for identifying financial relationships between individuals in control of educational content and ineligible companies and managing them to ensure they do not introduce commercial bias.

Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company. The Accreditation Council for Continuing Medical Education (ACCME) defines an ineligible company as an organization “whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." The ACCME does not consider clinical service providers directly to patients as ineligible companies. Ineligible companies are prohibited from engaging in joint providership with accredited providers.

DMU must collect information from all planners, faculty, and others in control of educational content about all their financial relationships with ineligible companies within the prior 24 months. There is no minimum monetary threshold; individuals must disclose all financial relationships with ineligible companies regardless of the amount. Individuals must disclose, irrespective of their view the relevance of the relationship to education. Any individual who refuses to disclose relevant financial relationships will be disqualified from developing, managing, presenting, or evaluating the activity. The disclosure intends not to prevent an individual from being involved in a continuing education activity but to provide learners with information to make judgments. This disclosure policy is intended to protect all parties involved from any potential conflict of interest that may arise.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Ali Khalifeh, MD - Medical Director
  • Angela Churilla, MA - Activity Coordinator
  • Ankur Chandra, MD - Medical Director
  • Ashley Vavra, MD - Medical Director
  • Ashley Verhyen, MSN, RN - Data Manager
  • Benjamin Jacobs, MD - Associate Medical Director
  • Bethany Taylor, RCP, RRT - Data Manager
  • Betsy Wymer, DNP, RN, CTTS, CV-BC - Speaker
  • Brian Adams, MD - Associate Medical Director
  • Brooke Dolacky, RT(R)(CI), RCES - Data Manager
  • Carlos Moreno, MS, MBA - Data Manager
  • Caroline Morgan, BSN, RN - Speaker
  • Chun Li, MD, MPH - Associate Medical Director
  • Eleftherios S. Xenos, MD, PhD, RVT, FACS - Medical Director
  • Elizabeth Schwendler, RN, CCRP - Data Manager
  • Emily Malgor, MD, FACS - Medical Director
  • Faisal Aziz, MD, MBA, FACS - Medical Director
  • Igor Laskowski, MD, PhD - Associate Medical Director
  • James Wadzinski - Planning Committee Member
  • Jeffrey Siracuse, MD, MBA - Medical Director
  • Jennifer Correa, MS - Activity Coordinator
  • Jennifer Farrell, BSN, RN - Data Manager
  • Joseph Hart, MD, MHL, FACS, DFSVS - Medical Director
  • Joseph Jacot, PA-C - Data Manager
  • Julie Mason, RVT - Data Manager
  • Kendra Smith, RN, MSN, RCIS - Data Manager
  • Kourosh Keyhani, DO, FACS - Associate Medical Director
  • Kristina Giles, MD - Associate Medical Director
  • Larry Kraiss, MD - Activity Director, Moderator, and Speaker
  • M. Ashraf Mansour, MD - Activity Coordinator
  • Mary Wanzek, RN - Data Manager
  • Matthew Smith, MD, PhD - Associate Medical Director
  • Melinda Lewis, RN - Data Manager
  • Melissa Latus, RN - Speaker
  • Michael McNally, MD, FACS - Medical Director
  • Michael Stoner, MD, RVT, FACS - Medical Director
  • Miranda Witheford, MD, PhD, FRCSC - Associate Medical Director
  • Mohammad Eslami, MD, MPH, MBA, FACS, FACC - Associate Medical Director
  • Mrinal Shukla, MD, FACS, FSVS, RPVI - Associate Medical Director
  • Nora Patterson, RN - Data Manager
  • Patricia Bozeman, APRN, CVN - Data Manager
  • Paul White, MD - Medical Director
  • Renee Palmer, RN - Data Manager
  • Robin Acino, MPH - Data Manager
  • Susan VanAtta, RN - Data Manager
  • Stacey Esposito, MS, BSN, RN - Data Manager
  • Timothy Hodges, MD - Medical Director
  • Tracy Campin, BSN, RN - Data Manager
  • Vashisht Madabhushi, MD, MPH - Associate Medical Director
  • Yaasin Abdulrehman, MD, FRCSC - Medical Director
  • Young Erben, MD, FACS - Medical Director

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated either through peer review by individuals with no relevant financial relationships or attestation to adhere to evidence-based guidelines for clinical recommendations.

  • Julia Glaser, MD, FACS - Associate Medical Director
    • Honorarium: Novartis
    • The financial relationship has not ended; however, it is not relevant to the educational activity's content.
  • Katharine McGinigle, MD, MPH - Medical Director
    • Consultant: Medtronic, Orthofix, and Vascular Technologies
    • The financial relationships have not ended; however, they are not relevant to the educational activity's content.
  • Misty Humphries, MD, MAS - Associate Medical Director
    • Consultant: Boston Scientific and Johnson and Johnson
    • Grant or Research Support: Inspire MD, Medtronic, and W.L. Gore
    • The financial relationships have not ended, and they are relevant to the educational activity's content.
  • Momodou Jammeh, MD - Associate Medical Director
    • Consultant: Medtronic
    • The financial relationship has not ended; however, it is not relevant to the educational activity's content.
  • Shipra Arya, MD, SM, FACS - Medical Director
    • Consultant: Novartis Pharmaceuticals
    • The financial relationship has not ended; however, it is not relevant to the educational activity's content.